DUBLIN, January 23, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/n8zwpc/lyophilized) has announced the addition of the "Lyophilized Injectables" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The inherent instability of protein drugs is a limitation that has a direct impact on the drug delivery sector. Therapeutic proteins must either be stored under special conditions or formulated to retain their efficacy from the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed - a requirement referred to as the cold chain'.
Alternatively, proteins can be formulated as powders (lyophilization). Lyophilized proteins must be reconstituted prior to injection. Lyophilized drugs are sold with reconstitution vial systems, or packaged in special injection devices (e.g., pens, needle-free injectors, two-part syringes) that allow reconstitution to take place in the device prior to injection
What You Will Learn:
Key Topics Covered:
Executive Summary
The Market Opportunity
Delivery Market Dynamics
Lyophilized Drugs - Primary Packaging
Single Use Vials
Lyophilized Drugs - Reconstitution and Delivery
Prefilled Diluent Syringes
Lyophilized Drugs - Key Therapeutic Sector Analysis and Market Data
Antibiotics
Profiles
For more information visit http://www.researchandmarkets.com/research/n8zwpc/lyophilized
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article